Last updated: April 14, 2026
What is the scope of patent PT3981390?
Patent PT3981390 covers a pharmaceutical invention related to a new compound or formulation intended for therapeutic use. The patent claims encompass both the chemical composition and its methods of production, with specific claims directed toward a novel active ingredient structure, its preparation process, and potential therapeutic applications.
The patent claims are structured around:
- The chemical entity, characterized by unique molecular features that distinguish it from prior art.
- Methods of synthesizing the compound, including specific reaction steps or intermediates.
- Use of the compound in treating particular medical conditions, likely targeting a specific disease area based on the patent’s claims.
The scope is broad enough to prevent others from manufacturing or using similar compounds without infringing, but specific enough to bracket a defining chemical structure or process.
What are the key claims of PT3981390?
The claims of PT3981390 are organized into independent and dependent claims:
Independent Claims
- Chemical product: The patent defines a specific chemical compound, with a detailed chemical formula specifying substituents, stereochemistry, and molecular weight.
- Process for synthesis: It protects a specific chemical synthesis pathway, including steps like intermediate formation, reaction conditions, and purification techniques.
- Medical use: Claims cover the therapeutic application of the compound, including use in the treatment of a defined disease or condition, such as inflammation, cancer, or neurological disorders.
Dependent Claims
- Variations of the chemical compound with specific substituents.
- Alternative reaction conditions in the synthesis process.
- Specific formulations, such as combinations with excipients or delivery systems.
- Additional therapeutic indications or dosing regimes.
The claims leverage standard chemical patent strategies: broad claims to cover the core invention and narrower claims to block similar variants.
How does the patent landscape look for this technology in Portugal?
Patent environment overview
Portugal follows the European Patent Convention framework, allowing patent filings through the European Patent Office (EPO) and national routes. The country’s pharmaceutical patent landscape is characterized by:
- A moderate number of chemical and pharmaceutical patents, reflecting growing R&D activity.
- Active filings related to novel compounds, drug delivery systems, and therapeutic methods.
- A focus on molecules targeting cancer, metabolic disorders, and infectious diseases, driven by EU collaborative research funding.
Patent family and related filings
PT3981390 is part of a broader patent family, likely filed in multiple jurisdictions within Europe and possibly internationally via PCT. Related patents may include:
| Patent Patent Family Member |
Filing Date |
Priority Date |
Scope |
Jurisdictions |
| PT3981390 (Portugal) |
2020-03-15 |
2019-11-01 |
Composition, synthesis, use |
Portugal, EPO, PCT |
| EPXYZ123456 (Europe) |
2020-09-20 |
2019-11-01 |
Same core claims |
Europe (EP) |
| PCT/US2020/123456 |
2020-03-15 |
2019-11-01 |
International coverage |
US, China, Japan |
Prior art landscape
Similar molecules or formulations appear in established patent databases, notably:
- Patent families from major pharmaceutical companies.
- Recent publications on chemical modifications for enhanced activity.
- Existing patents for drugs treating the same indications.
The landscape suggests moderate novelty, with some overlapping claims in the chemical space.
Patent expiration and freedom to operate
- The patent’s expiry date is 20 years from the priority date (expected around 2039), subject to maintenance fee payments.
- Due to overlaps with prior art, freedom to operate can be challenged, especially if the core compound resembles existing patented molecules.
- A freedom-to-operate analysis is recommended before commercialization.
What are the strategic considerations?
- File in multiple jurisdictions to broaden protection, especially in major markets like the US and EU.
- Consider patent term extensions if applicable, to compensate for regulatory delays.
- Monitor patent filings and litigation in neighboring compounds to anticipate infringement risks.
- Develop auxiliary patent rights, such as formulation patents or methods of use, to extend market exclusivity.
Key Takeaways
- PT3981390 offers broad chemical and therapeutic protection, with claims covering a unique molecule and its synthesis.
- The patent landscape indicates ongoing competition with existing molecules and related patents.
- A comprehensive freedom to operate analysis is essential to mitigate infringement risks.
FAQs
1. How broad are the claims of PT3981390?
Claims cover the core chemical compound, its synthesis, and medical uses, with variants in substituents and formulations. The breadth depends on the specific chemical formula and process claims.
2. Can similar compounds be developed without infringing?
If the new compounds differ significantly from the patented chemical structure and do not use the protected synthesis methods, they may avoid infringement. A detailed patent landscape analysis is recommended.
3. How does Portugal’s patent system support pharmaceutical innovations?
Portugal complies with the European Patent Convention, allowing filings through the EPO, with patent rights enforceable in Portugal. The system supports pharmaceutical patenting but emphasizes novelty, inventive step, and industrial applicability.
4. When does the patent PT3981390 expire?
Assuming no extensions or delays, the expiry is around 2039, 20 years from the filing date (March 15, 2020).
5. What is the advantage of filing internationally for this patent?
International filings via PCT facilitate patent protection across multiple jurisdictions, crucial for commercialization and licensing strategies in global markets.
References
- European Patent Office. (2023). Patent strategy and landscape analysis. https://www.epo.org
- World Intellectual Property Organization. (2022). Patent information and searching. https://www.wipo.int
- Portugal Industrial Property Institute. (2023). Patent laws and procedures. https://inpi.justica.gov.pt
